Center for Immunology and Microbial Disease, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.
Exp Gerontol. 2009 Aug;44(8):503-10. doi: 10.1016/j.exger.2009.04.005. Epub 2009 May 3.
Many age-associated degenerative diseases commonly involve degradation of the extracellular matrix and aberrant matrix metalloproteinase-1 (MMP-1) expression. In diverse cell lines MMP-1 or interstitial collagenase (CL) expression is tightly regulated through a network of signals involving reactive oxygen species (ROS). However, whether the in vivo age-associated increase in CL expression is also sensitive to ROS-mediated signaling has not been established. To evaluate the contribution of ROS to the age-dependent increase in CL we monitored the levels of murine CL in two well-established models of oxidant stress. Analysis of murine CL levels in mice deficient in either of the intracellular superoxide dismutases (Sod2(+/-) or Sod1(-/-)) revealed its age- and redox-dependent expression relative to WT controls. Both age- and redox-dependent increases in murine CL expression were associated with elevations in phosphorylation of the MAP Kinases, Erk, JNK and p38. CL expression was highest in renal and skeletal muscle tissue from the aged Sod1(-/-) mice and was associated with a decrease in collagen staining. These findings suggest that MAPK signaling and CL production are both age- and redox-responsive. The redox sensitivity of age-associated CL expression suggests that degenerative disease associated with aberrant matrix remodeling and oxidant stress may be amenable to antioxidant-based therapies.
许多与年龄相关的退行性疾病通常涉及细胞外基质的降解和基质金属蛋白酶-1(MMP-1)表达的异常。在不同的细胞系中,MMP-1 或间质胶原酶(CL)的表达通过涉及活性氧(ROS)的信号网络进行严格调节。然而,体内与年龄相关的 CL 表达增加是否也对 ROS 介导的信号敏感尚未确定。为了评估 ROS 对 CL 表达随年龄增加的贡献,我们在两种已建立的氧化应激模型中监测了小鼠 CL 的水平。分析两种细胞内超氧化物歧化酶(Sod2(+/-)或 Sod1(-/-))缺陷小鼠的小鼠 CL 水平,揭示了其与 WT 对照相比的年龄和氧化还原依赖性表达。CL 表达的年龄和氧化还原依赖性增加均与 MAP 激酶、Erk、JNK 和 p38 的磷酸化升高相关。Sod1(-/-) 老年小鼠的肾脏和骨骼肌组织中 CL 表达最高,与胶原染色减少有关。这些发现表明,MAPK 信号和 CL 产生均对年龄和氧化还原有反应。与年龄相关的 CL 表达的氧化还原敏感性表明,与异常基质重塑和氧化应激相关的退行性疾病可能对基于抗氧化剂的治疗方法有效。